Skip to main content Skip to search Skip to main navigation
Menu

EC analytical columns NUCLEODUR® 100-3

Description
Totally spherical high purity silica - USP L3 pore size 110 Å, pore volume 0.9 ml/g, surface (BET) 340 m²/g, density 0.47 g/ml, pressure stability 800 bar, pH stability 2 - 8.

Particle size 3 µm.

Properties
Eluent in column: n-heptane
Endcapped: No
Int. Ø: 4.6 mm
Length: 150 mm
Manufacturer Article Number: 760172.46
Material column: Stainless steel
Max. temperature resistance: 60 °C
Method: Analytical
Particle size: 3 µm
Particle type: Fully porous
Separation system: Normal phase
USP listing: L3
Volume column: 2.5 ml
pH stability: 2 ... 8
Skip product gallery

Similar products

EC analytical columns NUCLEODUR® C18 Gravity, 1.8 µm
NUCLEODUR® C18 - C 8 Gravity nonpolar high density phasesAvailable as octadecyl (C18 -USP L1) and octyl (C8 - USP L7) modifications. Pore size 110 Å.Ideal for method developmentAllows HPLC at pH extremes (pH 1 - 11)Suitable for LC/MS due to low bleeding characteristicsRecommended for overall sophisticated analytical separationsOptimal for: pharmaceuticals, e.g. analgesics, antiinflammatory drugs, antidepressants, herbicides, phytopharmaceuticals, immunosppressantsParticle size 1.8 µm, 18 % C
From CHF 750.90*

EC analytical columns NUCLEODUR® C18 Gravity, 3 µm
NUCLEODUR® C18 - C 8 Gravity nonpolar high density phasesAvailable as octadecyl (C18 -USP L1) and octyl (C8 - USP L7) modifications. Pore size 110 Å.Ideal for method developmentAllows HPLC at pH extremes (pH 1 - 11)Suitable for LC/MS due to low bleeding characteristicsRecommended for overall sophisticated analytical separationsOptimal for: pharmaceuticals, e.g. analgesics, antiinflammatory drugs, antidepressants, herbicides, phytopharmaceuticals, immunosppressantsParticle size 3 µm, 18 % C.
From CHF 750.90*

EC analytical columns NUCLEODUR® C18 Gravity, 5 µm
NUCLEODUR® C18 - C 8 Gravity nonpolar high density phasesAvailable as octadecyl (C18 -USP L1) and octyl (C8 - USP L7) modifications. Pore size 110 Å.Ideal for method developmentAllows HPLC at pH extremes (pH 1 - 11)Suitable for LC/MS due to low bleeding characteristicsRecommended for overall sophisticated analytical separationsOptimal for: pharmaceuticals, e.g. analgesics, antiinflammatory drugs, antidepressants, herbicides, phytopharmaceuticals, immunosppressantsParticle size 5 µm, 18 % C
From CHF 604.80*

EC analytical columns NUCLEODUR® 100-5 CN, 5 µm
Pore size 110 Å, - USP L10Multi-mode columns (RP and NP)Widens the scope in selectivityDiffernet retention characteristics compared to C8 and C18Stable against hydrolysis at low pH values, working range pH 1-8High reproducibility from lot to lotIdeal for: tricyclic antidepressants, steroids, organic acidsEluent in column n-heptane, particle size 5 µm.
From CHF 415.40*

EC analytical columns NUCLEODUR® 100-5 CN-RP, 5 µm
Pore size 110 Å, - USP L10Multi-mode columns (RP and NP)Widens the scope in selectivityDiffernet retention characteristics compared to C8 and C18Stable against hydrolysis at low pH values, working range pH 1-8High reproducibility from lot to lotIdeal for: tricyclic antidepressants, steroids, organic acidsEluent in column acetonitrile, particle size 5 µm
From CHF 415.40*

EC analytical columns NUCLEODUR® C18 Pyramid, 5 µm
Stable in 100 % aqueous eluent systems- USP L1Pore size 110 ÅInteresting polar selectivity featuresExcellent base deactivation; suitable for LC/MS due low bleeding characteristicspH stability 1 - 9Ideal for: analgesics, penicillin antibiotics, nucleic acid bases, water-soluble vitamins, complexing agetns, organic acidsParticle size 5 µm, 14 % C
From CHF 604.80*

EC analytical columns NUCLEODUR® C18 Pyramid, 3 µm
Stable in 100 % aqueous eluent systems- USP L1Pore size 110 ÅInteresting polar selectivity featuresExcellent base deactivation; suitable for LC/MS due low bleeding characteristicspH stability 1 - 9Ideal for: analgesics, penicillin antibiotics, nucleic acid bases, water-soluble vitamins, complexing agetns, organic acidsParticle size 3 µm, 14 % C
From CHF 750.90*

EC analytical columns NUCLEODUR® C18 Pyramid, 1.8 µm
Stable in 100 % aqueous eluent systems- USP L1Pore size 110 ÅInteresting polar selectivity featuresExcellent base deactivation; suitable for LC/MS due low bleeding characteristicspH stability 1 - 9Ideal for: analgesics, penicillin antibiotics, nucleic acid bases, water-soluble vitamins, complexing agetns, organic acidsParticle size 1.8 µm, 14 % C.
From CHF 750.90*

EC analytical columns NUCLEODUR® C18 Isis, 3 µm
C18 phase with special polymeric, crosslinked surface modification - USP L1Pore size 110 ÅHigh steric selectivityOutstanding surface deactivationSuitable for LC/MS due low bleeding characteristicspH stability 1 - 10Broad range of application: steroids, (o,p,m-) substituted aromatics, fat-soluble vitaminsParticle size 3 µm, 20 % C
From CHF 750.90*

EC analytical columns NUCLEODUR® 100-5 C18 ec, 5 µm
Available with medium density octadecyl (C18 - USP L1) and octyl (C8 - USP L7) modification pore size 110 Å, particle sizes 3 µm and 5 µm; 7 µm, 10 µm, 12 µm, 16 µm, 20 µm, 30 µm und 50 µm for preparative separations on request for daily routine analysis and up-scaling for preparative HPLC, pH stability 1 - 9. Carbon content 17.5 % C for C18, 10.5 % C for C8, high reproducibility from lot to lot for standard routine applications in reversed phase chromatography.Octadecyl phases, 17.5 % C, particle size 5 µm.
From CHF 297.30*